Menopause news

HRT after Breast cancer

21 Feb 2007

The treatment of menopausal symptoms in women who have had breast cancer continues to be difficult. There is concern about using HRT after breast cancer, particularly since previous studies have shown conflicting results about risk of recurrence yet non-hormonal treatments are less effective than HRT for controlling menopausal symptoms. A recent study has shown encouraging results with the use of tibolone in women who have had breast cancer. A group in Greece followed women who had had breast cancer for up to 6 years. Some of the women had taken tibolone for menopausal symoptoms for a mean duration of 37 months. Tibolone use did not appear to increase the risk of recurrence of cancer, although it is accepted that the study was small. Ref 37

A larger study of the use of tibolone after breast cancer is ongoing and the results are eagerly awaited. Meanwhile, the treatment of menopausal symptoms in women who have had breast cancer will continue to be difficult and controversial.

< Go Back

<< News Index